Old Ayala, Inc
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|
| Revenue | $692,000 | $3.5M | $3.7M | $2.3M |
| Operating income | −$37.5M | −$39.2M | −$29.8M | −$17.7M |
| Net income | −$38.0M | −$40.3M | −$30.1M | −$17.8M |
| Total assets | $7.8M | $41.1M | $45.8M | $20.1M |
| Total liabilities | — | — | — | — |
| Equity | −$1.1M | $34.2M | $38.4M | −$38.9M |
| EPS (diluted) | $-2.46 | $-2.80 | — | — |
| Shares out. | 14.1M | 13.2M | 12.7M | 5.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −5419.5%
- Net margin
- −5493.2%
- Return on equity
- 3458.9%
- Return on assets
- −489.3%
- Return on capital (ROCE)
- −16095.7%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-0.08
- Revenue growth (YoY)
- −80.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Accruals / assets
- −45.1%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 warning● 2 good- Negative shareholder equity
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Other material eventJan 25, 2023
- Shareholder voteJan 13, 2023
- Other material eventJan 4, 2023
- Delisting / listing-standard noticeNov 23, 2022
- Delisting / listing-standard noticeNov 17, 2022
- Entered a material agreement · Director / officer change · Regulation FD disclosureOct 19, 2022
- Other material eventSep 12, 2022
- Other material eventJul 5, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 3Nov 1, 2023
- 3Nov 1, 2023
- 3Oct 31, 2023
- 10-KANNUAL REPORTMar 31, 2023
- SC 13G/AFeb 8, 2023
- SC 13GFeb 7, 2023
- SC 13G/ASEC SCHEDULE 13GFeb 6, 2023
- 15-12GJan 30, 2023
- 8-KJan 25, 2023
- 4Jan 24, 2023
- EFFECTJan 23, 2023
- EFFECTJan 23, 2023
- 4OWNERSHIP DOCUMENTJan 23, 2023
- 4OWNERSHIP DOCUMENTJan 23, 2023
- 4OWNERSHIP DOCUMENTJan 23, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.